Clientfirst Wealth Management LLC Acquires New Position in ARK Genomic Revolution ETF (BATS:ARKG)

Clientfirst Wealth Management LLC bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the fourth quarter, Holdings Channel reports. The fund bought 9,670 shares of the company’s stock, valued at approximately $228,000.

Other institutional investors also recently bought and sold shares of the company. Union Bancaire Privee UBP SA purchased a new stake in shares of ARK Genomic Revolution ETF during the 4th quarter valued at approximately $45,000. National Bank of Canada FI increased its stake in ARK Genomic Revolution ETF by 28.4% during the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after acquiring an additional 920 shares during the last quarter. IHT Wealth Management LLC purchased a new stake in ARK Genomic Revolution ETF in the third quarter valued at $203,000. Hilltop Holdings Inc. acquired a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at $237,000. Finally, Sanctuary Advisors LLC purchased a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter worth $222,000.

ARK Genomic Revolution ETF Stock Performance

Shares of ARKG opened at $26.94 on Friday. The firm has a 50-day moving average of $25.42 and a 200-day moving average of $25.24.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.